Structural Optimization of Diphenylpyrimidine Scaffold as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation in Non ‐small Cell Lung Cancer

Chemical Biology&Drug Design,Volume 0, Issue ja, -Not available-.

Source: Chemical Biology and Drug Design - July 21, 2018 Category: Biology Authors: Yuanyuan Yi , Luhong Wang , Dan Zhao , Shanshan Huang , Changyuan Wang , Zhihao Liu , Huijun Sun , Kexin Liu , Xiaodong Ma , Yanxia Li Source Type: research